Pentwater Capital Management LP Blueprint Medicines Corp Transaction History
Pentwater Capital Management LP
- $15 Billion
- Q2 2025
A detailed history of Pentwater Capital Management LP transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Pentwater Capital Management LP holds 3,900,000 shares of BPMC stock, worth $505 Million. This represents 3.34% of its overall portfolio holdings.
Number of Shares
3,900,000Holding current value
$505 Million% of portfolio
3.34%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
401Shares Held
67.4MCall Options Held
1.12MPut Options Held
1.67M-
Black Rock Inc. New York, NY6.65MShares$861 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.42MShares$831 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.51MShares$324 Million0.02% of portfolio
-
State Street Corp Boston, MA2.23MShares$289 Million0.01% of portfolio
-
Ubs Group Ag2.17MShares$281 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $7.73B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...